Drug Profile
Research programme: PPAR modulators - AltruBio
Alternative Names: AbGn-L; AbGn-XLatest Information Update: 06 Jul 2020
Price :
$50
*
At a glance
- Originator AbGenomics Corporation
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Metabolic disorders; Type 2 diabetes mellitus
Most Recent Events
- 04 Aug 2005 Preclinical trials in Metabolic disorders in Taiwan (unspecified route)
- 04 Aug 2005 Preclinical trials in Type-2 diabetes mellitus in Taiwan (unspecified route)